Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -8.82 Million USD | 43.38% |
| 2023 | -15.59 Million USD | 12.79% |
| 2022 | -17.87 Million USD | -33.23% |
| 2021 | -13.41 Million USD | -22.95% |
| 2020 | -10.91 Million USD | -27.02% |
| 2019 | -8.59 Million USD | -11.24% |
| 2018 | -7.72 Million USD | -29.98% |
| 2017 | -5.94 Million USD | -15.83% |
| 2016 | -5.13 Million USD | -5574.28% |
| 2015 | -90.4 Thousand USD | 0.73% |
| 2014 | -91.07 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -8.82 Million USD | 43.38% |
| 2024 Q1 | -2.29 Million USD | -3.09% |
| 2024 Q3 | -1.28 Million USD | 44.81% |
| 2024 Q4 | -3.04 Million USD | -137.51% |
| 2024 Q2 | -2.32 Million USD | -1.12% |
| 2023 Q3 | -4.36 Million USD | -7.38% |
| 2023 Q2 | -4.06 Million USD | 0.55% |
| 2023 FY | -15.59 Million USD | 12.79% |
| 2023 Q1 | -4.08 Million USD | 20.66% |
| 2023 Q4 | -2.22 Million USD | 48.98% |
| 2022 Q4 | -5.15 Million USD | -3.06% |
| 2022 Q3 | -5 Million USD | 16.47% |
| 2022 Q2 | -5.98 Million USD | -98.08% |
| 2022 Q1 | -3.02 Million USD | 24.77% |
| 2022 FY | -17.87 Million USD | -33.23% |
| 2021 Q1 | -3.57 Million USD | 20.06% |
| 2021 FY | -13.41 Million USD | -22.95% |
| 2021 Q2 | -2.84 Million USD | 20.25% |
| 2021 Q3 | -3.86 Million USD | -35.79% |
| 2021 Q4 | -4.01 Million USD | -3.82% |
| 2020 Q2 | -2 Million USD | 3.9% |
| 2020 Q3 | -2.34 Million USD | -16.85% |
| 2020 FY | -10.91 Million USD | -27.02% |
| 2020 Q1 | -2.08 Million USD | -14.65% |
| 2020 Q4 | -4.46 Million USD | -90.48% |
| 2019 Q1 | -2.42 Million USD | 13.29% |
| 2019 FY | -8.59 Million USD | -11.24% |
| 2019 Q3 | -2.17 Million USD | 0.21% |
| 2019 Q2 | -2.17 Million USD | 10.07% |
| 2019 Q4 | -1.82 Million USD | 16.1% |
| 2018 Q1 | -1.38 Million USD | 10.64% |
| 2018 Q2 | -1.45 Million USD | -5.29% |
| 2018 Q3 | -2.09 Million USD | -44.04% |
| 2018 Q4 | -2.79 Million USD | -33.21% |
| 2018 FY | -7.72 Million USD | -29.98% |
| 2017 Q1 | -800.8 Thousand USD | -38.88% |
| 2017 Q4 | -1.54 Million USD | 29.46% |
| 2017 FY | -5.94 Million USD | -15.83% |
| 2017 Q3 | -2.19 Million USD | -56.24% |
| 2017 Q2 | -1.4 Million USD | -75.21% |
| 2016 Q2 | -1.22 Million USD | -149.3% |
| 2016 FY | -5.13 Million USD | -5574.28% |
| 2016 Q4 | -576.62 Thousand USD | 59.86% |
| 2016 Q3 | -1.43 Million USD | -17.11% |
| 2016 Q1 | -492.01 Thousand USD | 0.0% |
| 2015 Q1 | -28.14 Thousand USD | 0.0% |
| 2015 Q2 | -21.07 Thousand USD | 25.11% |
| 2015 Q3 | -18.9 Thousand USD | 10.31% |
| 2015 FY | -90.4 Thousand USD | 0.73% |
| 2014 FY | -91.07 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 38.526% |
| Cerus Corporation | -30.05 Million USD | 70.624% |
| OrthoPediatrics Corp. | -25.76 Million USD | 65.737% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 16.882% |
| Talis Biomedical Corporation | -66.81 Million USD | 86.787% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 48.958% |
| Inogen, Inc. | -109.38 Million USD | 91.929% |
| Spectral AI, Inc. | -12.98 Million USD | 32.007% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 85.895% |
| CVRx, Inc. | -43.1 Million USD | 79.518% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -150.234% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 28.965% |
| Orthofix Medical Inc. | -139.11 Million USD | 93.654% |
| Venus Concept Inc. | -28.3 Million USD | 68.815% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 83.66% |
| Bioventus Inc. | -81.72 Million USD | 89.198% |
| BrainsWay Ltd. | -4.92 Million USD | -79.181% |
| Envoy Medical, Inc. | -18.37 Million USD | 51.945% |
| electroCore, Inc. | -18.8 Million USD | 53.054% |
| IceCure Medical Ltd | -15.57 Million USD | 43.321% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 81.791% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 48.875% |
| MaxCyte, Inc. | -48.29 Million USD | 81.722% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 26.156% |
| Nexalin Technology, Inc. | -5.69 Million USD | -54.983% |
| PAVmed Inc | -68.79 Million USD | 87.167% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 84.392% |
| RxSight, Inc. | -50.08 Million USD | 82.373% |
| Sight Sciences, Inc. | -57.27 Million USD | 84.586% |
| SI-BONE, Inc. | -46.93 Million USD | 81.189% |
| TELA Bio, Inc. | -44.07 Million USD | 79.97% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 83.697% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 82.834% |
| LivaNova PLC | -68.49 Million USD | 87.112% |
| 908 Devices Inc. | -42.75 Million USD | 79.353% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 94.909% |
| Nemaura Medical Inc. | -9.59 Million USD | 7.993% |
| NeuroPace, Inc. | -27.17 Million USD | 67.512% |
| LENSAR, Inc. | -12.22 Million USD | 27.809% |
| Apyx Medical Corporation | -17.25 Million USD | 48.848% |
| Cutera, Inc. | -156.23 Million USD | 94.349% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -2.607% |
| BioSig Technologies, Inc. | -28.51 Million USD | 69.037% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 89.927% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 60.669% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 107.916% |
| Axonics, Inc. | -26.05 Million USD | 66.119% |
| Outset Medical, Inc. | -169.77 Million USD | 94.8% |
| IRIDEX Corporation | -10 Million USD | 11.779% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 91.913% |
| IRadimed Corporation | 20.03 Million USD | 144.063% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -7.074% |
| INVO Bioscience, Inc. | -6.76 Million USD | -30.458% |
| Telesis Bio, Inc. | -35.15 Million USD | 74.884% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 161.607% |
| Varex Imaging Corporation | 32.1 Million USD | 127.502% |
| Quipt Home Medical Corp. | 3.91 Million USD | 325.268% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 27.238% |
| Pulmonx Corporation | -61.93 Million USD | 85.746% |
| Dynatronics Corporation | -2.27 Million USD | -288.389% |
| Modular Medical, Inc. | -17.52 Million USD | 49.636% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 39.693% |
| Semler Scientific, Inc. | 22.25 Million USD | 139.667% |
| InMode Ltd. | 195.66 Million USD | 104.512% |
| Bruker Corporation | 436.9 Million USD | 102.021% |
| Cytosorbents Corporation | -31.2 Million USD | 71.713% |
| DexCom, Inc. | 597.7 Million USD | 101.477% |
| Align Technology, Inc. | 643.33 Million USD | 101.372% |
| Viveve Medical, Inc. | -21.55 Million USD | 59.039% |
| ZimVie Inc. | -30.93 Million USD | 71.466% |
| Movano Inc. | -29.69 Million USD | 70.265% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 68.295% |
| Nexalin Technology, Inc. | -5.69 Million USD | -54.983% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -150.234% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 96.215% |
| Profound Medical Corp. | -28.61 Million USD | 69.149% |
| Insulet Corporation | 220 Million USD | 104.013% |
| enVVeno Medical Corporation | -25.23 Million USD | 65.02% |
| Surmodics, Inc. | -5.64 Million USD | -56.391% |
| iCAD, Inc. | -7.68 Million USD | -14.817% |
| Nuwellis, Inc. | -17.63 Million USD | 49.925% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 92.946% |
| Aethlon Medical, Inc. | -12.63 Million USD | 30.137% |
| InspireMD, Inc. | -21.14 Million USD | 58.245% |
| PAVmed Inc. | -68.79 Million USD | 87.167% |
| BIOLASE, Inc. | -17.93 Million USD | 50.782% |
| Beyond Air, Inc. | -63 Million USD | 85.988% |
| FONAR Corporation | 16.53 Million USD | 153.39% |
| AxoGen, Inc. | -21.46 Million USD | 58.866% |
| Vivani Medical, Inc. | -26.96 Million USD | 67.26% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 148.934% |
| Inari Medical, Inc. | -14.03 Million USD | 37.085% |
| UFP Technologies, Inc. | 57.66 Million USD | 115.31% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -79.16% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -40.003% |
| Tenon Medical, Inc. | -15.72 Million USD | 43.866% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -18.12% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 79.328% |
| AdaptHealth Corp. | -598.4 Million USD | 98.525% |
| Sintx Technologies, Inc. | -13.35 Million USD | 33.91% |
| NanoVibronix, Inc. | -3.43 Million USD | -156.934% |
| Quanterix Corporation | -49.7 Million USD | 82.237% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 27.238% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -2211.065% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 97.36% |
| TransMedics Group, Inc. | -28.72 Million USD | 69.268% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 62.611% |
| NeuroMetrix, Inc. | -7.15 Million USD | -23.446% |
| Hyperfine, Inc. | -48.11 Million USD | 81.652% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 86.423% |
| Biomerica, Inc. | -6.36 Million USD | -38.657% |
| Bone Biologics Corporation | -9.42 Million USD | 6.364% |
| AVITA Medical, Inc. | -40.4 Million USD | 78.149% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 14.382% |
| Silk Road Medical, Inc | -59.27 Million USD | 85.105% |